ALLISON STELLY: Open Payments
NPI 1215248935 · OLLA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 68 payments from 16 companies in 2025. Trend: 2023 $1,185 · 2024 $1,071 · 2025 $1,240
Food & beverage: $1,240
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $204 |
| Axsome Therapeutics, Inc. | 10 | $146 |
| PFIZER INC. | 6 | $115 |
| ABBVIE INC. | 6 | $110 |
| Abbott Laboratories | 3 | $106 |
| Novo Nordisk Inc | 6 | $98 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Amgen Inc. | 5 | $79 |
| Lilly USA, LLC | 3 | $45 |
Products named: Auvelity, REXULTI, FARXIGA, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, OTEZLA, ELIQUIS, BREZTRI.
Industry payments across LA — which companies pay providers there.
